JANE STREET GROUP, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J908. A total of 4 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$357,934
-31.7%
19,100
-21.1%
0.00%
Q4 2023$524,414
-63.9%
24,200
-65.7%
0.00%
Q3 2023$1,452,948
-58.4%
70,600
-5.0%
0.00%
-100.0%
Q2 2023$3,493,586
+14.2%
74,300
+1.9%
0.00%0.0%
Q1 2023$3,058,884
-20.1%
72,900
-27.4%
0.00%
-50.0%
Q4 2022$3,829,256
-14.5%
100,400
-12.2%
0.00%0.0%
Q3 2022$4,480,000
+276.8%
114,400
+210.9%
0.00%
+100.0%
Q2 2022$1,189,00036,8000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 1,000$3,013,0000.78%
SABBY MANAGEMENT, LLC 4,009$12,079,0000.63%
Iguana Healthcare Management, LLC 50,000$1,507,0000.61%
SIMPLEX TRADING, LLC 38$8,0000.00%
GROUP ONE TRADING, L.P. 100$3,0000.00%
Citadel Advisors 11,500$346,0000.00%
View complete list of SAGE THERAPEUTICS INC shareholders